Kush Dhody

489 total citations
5 papers, 129 citations indexed

About

Kush Dhody is a scholar working on Infectious Diseases, Oncology and Neurology. According to data from OpenAlex, Kush Dhody has authored 5 papers receiving a total of 129 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Infectious Diseases, 2 papers in Oncology and 1 paper in Neurology. Recurrent topics in Kush Dhody's work include SARS-CoV-2 and COVID-19 Research (2 papers), COVID-19 Clinical Research Studies (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Kush Dhody is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (2 papers), COVID-19 Clinical Research Studies (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Kush Dhody collaborates with scholars based in United States. Kush Dhody's co-authors include Kazem Kazempour, Nader Pourhassan, Jonah B. Sacha, Denis R. Burger, Paul J. Maddon, Anne‐Marie Leuck, Otto O. Yang, Kabir Mody, Harish Seethamraju and Jennifer A. Fulcher and has published in prestigious journals such as Cancer Research, Clinical Infectious Diseases and American Journal of Infection Control.

In The Last Decade

Kush Dhody

5 papers receiving 125 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kush Dhody United States	5	68	31	26	24	21	5	129
Milagros González‐Rivera Spain	5	65 1.0×	36 1.2×	23 0.9×	9 0.4×	18 0.9×	5	134
Matteo Augello Italy	9	102 1.5×	27 0.9×	25 1.0×	11 0.5×	33 1.6×	24	164
Tianjun Jiang China	10	97 1.4×	35 1.1×	49 1.9×	18 0.8×	82 3.9×	21	227
Léo Plaçais France	7	63 0.9×	30 1.0×	72 2.8×	11 0.5×	8 0.4×	20	160
Hassan Tarhini France	5	132 1.9×	39 1.3×	14 0.5×	24 1.0×	20 1.0×	8	188
N. A. Аrsentieva Russia	8	143 2.1×	83 2.7×	46 1.8×	22 0.9×	15 0.7×	40	215
Pascale Martres France	5	101 1.5×	18 0.6×	15 0.6×	11 0.5×	32 1.5×	11	145
Renaud Cezar France	7	54 0.8×	21 0.7×	26 1.0×	11 0.5×	28 1.3×	19	139
Michael Cartwright United States	5	52 0.8×	21 0.7×	92 3.5×	13 0.5×	43 2.0×	8	201
Adolfo Firpo‐Betancourt United States	7	188 2.8×	41 1.3×	14 0.5×	33 1.4×	23 1.1×	16	250

Countries citing papers authored by Kush Dhody

Since Specialization

Citations

This map shows the geographic impact of Kush Dhody's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kush Dhody with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kush Dhody more than expected).

Fields of papers citing papers by Kush Dhody

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kush Dhody. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kush Dhody. The network helps show where Kush Dhody may publish in the future.

Co-authorship network of co-authors of Kush Dhody

This figure shows the co-authorship network connecting the top 25 collaborators of Kush Dhody. A scholar is included among the top collaborators of Kush Dhody based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kush Dhody. Kush Dhody is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Lalezari, Jacob, Kabir Mody, Harish Seethamraju, et al.. (2021). Disruption of CCR5 signaling to treat COVID-19-associated cytokine storm: Case series of four critically ill patients treated with leronlimab. Journal of Translational Autoimmunity. 4. 100083–100083. 44 indexed citations

2.

Cristofanilli, Massimo, Marek Doležal, Jay Lalezari, et al.. (2020). Abstract CT233: Phase Ib/II study of leronlimab (PRO 140) combined with carboplatin in CCR5+ mTNBC patients. Cancer Research. 80(16_Supplement). CT233–CT233. 6 indexed citations

3.

Fulcher, Jennifer A., David Goodman‐Meza, Kush Dhody, et al.. (2020). Clinical Characteristics and Outcomes of Coronavirus Disease 2019 Patients Who Received Compassionate-Use Leronlimab. Clinical Infectious Diseases. 73(11). e4082–e4089. 24 indexed citations

4.

Dhody, Kush, et al.. (2018). PRO 140, a monoclonal antibody targeting CCR5, as a long-acting, single-agent maintenance therapy for HIV-1 infection. HIV Clinical Trials. 19(3). 85–93. 34 indexed citations

5.

Leuck, Anne‐Marie, James R. Johnson, Matthew A. Hunt, et al.. (2015). Safety and efficacy of a novel silver-impregnated urinary catheter system for preventing catheter-associated bacteriuria: A pilot randomized clinical trial. American Journal of Infection Control. 43(3). 260–265. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact